Navigation Links
The structural basis of familial hypertrophic cardiomyopathy is revealed
Date:11/9/2007

Familial Hypertrophic Cardiomyopathy (FHC), the leading cause of sudden death in athletes and young people, is a genetic disorder of the heart that is characterized by an increased thickness in tissue of the left ventricle. FHC is thought to be caused by a mutation in the myosin heavy chain, one of the components of muscle cells in the heart, which causes a disruption in the normal alignment of muscle cells otherwise known as myocardial disarray. One of the deadliest forms of FHC is caused by the R403Q mutation, which kills 50% of those affected individuals by 40 years of age. A study conducted by scientists at the Burnham Institute for Medical Research (Burnham Institute) in La Jolla, CA provides new structural evidence that the disarray at the molecular level caused by the R403Q point mutation in myosin is linked to the characteristic misalignment of muscle cells in FHC.

In a recent publication by PloS ONE, the scientific group, led by Dr. Dorit Hanein (Burnham Institute), used smooth muscle myosin to investigate the structural effects of the R403Q mutation. The group concluded that this point mutation severely disrupts actin-myosin interactions as compared to those in wildtype myosin. While myosin normally attaches to the actin filament at a fixed angle, the mutated myosin displayed a wide variety of angles at the attachment sites, thus demonstrating a structural basis for the change in function of the mutant myosin. Dr. Hanein illustrates how the conformational instability within the sarcomere affects ability of the heart to function properly and may lead to compensatory hypertrophy in cardiac muscle tissue, which is a trademark phenotype of FHC. This study allows for a better understanding of the origination of FHC at the molecular level, which may open doors for the development of drugs to treat this disorder in the future.


'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. Imaging shows structural changes in mild traumatic brain injury
2. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
3. APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto
4. MS that runs in families appears more severe than non-familial MS
5. Familial MS May Be More Destructive
6. Major differences revealed in how local authorities in the UK support disabled people
7. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
Breaking Medicine Technology: